Author Archives: Best Practices

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Author:

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. While this

Best Practices Hosts 7th Digital Marketing Consortium Roundtable

Author:

Best Practices hosted our 7th Digital Marketing Consortium Roundtable on Thursday, July 23. The topic of the virtual conference was “Key Trends & Innovative Activities in 2015 Biopharma Digital Marketing.” The roundtable brought together executives from 8 leading pharmaceutical companies

Overcoming Regulatory Risks and Gaining Critical Insights through Social Media Listening

Author:

The pharmaceutical industry as a whole has struggled to delve into the social media world. The main reason for this is due to regulatory restrictions, with organizations fearful to engage in online conversations with patients due to the perceived high

Best Practices Hosting 6th Medical Affairs Consortium on HEOR

Author:

Best Practices will be hosting the sixth roundtable of our Medical Affairs Consortium on Thursday (May 28th) from 11:00AM-12:30PM (EST) via a virtual roundtable to discuss “Medical Affairs’ Role in Health Economics & Outcomes Research.” This is the final roundtable

Exclusive: Key Findings from Best Practices’ 5th Medical Affairs Consortium

Author:

Best Practices recently completed the second roundtable of our 2014-2015 Medical Affairs Consortium. The roundtable addressed the topic of “Medical Affairs Launch Support.” The roundtable brought together executives from 13 leading pharmaceutical organizations. Some exclusive key findings from the discussion

Top Trends in 2015 – Is Your Organization Prepared?

Author:

2015 is here & with the New Year comes many new trends and topics of discussion. With the increasing importance of payers and high demand on evidence-based information, it is clear that there are many shifts happening in the pharmaceutical,

Best Practices in Lifecycle Management: Maximizing the Potential of Mature Brands

Author:

As many drugs are reaching the patent cliff, strategies to extend the commercial life of mature brands is critical to today’s pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as 10 years and billions of dollars to

Medical Affairs Consortium: Impact Measures, Globalization & Compliance

Author:

On November 6, 2014 Best Practices, LLC hosted the 1st roundtable of the 2014-2015 Medical Affairs’ Consortium. The roundtable brought together leaders from: Baxter, Crescendo, Eli Lilly, Genentech, Incyte Corporation, Jazz Pharmaceuticals, Pfizer, Santen Inc., Teva, and Upsher-Smith. Leaders from

Best Practices’ Hosting Medical Affairs Consortium Roundtable Thursday, Nov. 6

Author:

Best Practices designed the Medical Affairs Consortium to provide Medical Affairs leaders with a forum for sharing insights about the key challenges they face. The consortium has developed a mechanism for creating and sharing solutions through three virtual roundtable discussions

Pharma Companies Feeling the Heat From the Sunshine Act

Author:

Last week marked the release of the initial data from the Sunshine Act law of the Affordable Care Act, which had been dreaded by many health care professionals and pharmaceutical and medical device executives. So, for the past few years,

Thou Shalt Build Credibility But Plan for the Worst

Author:

As pharma companies plan for the launch of new products, much of the discussion centers around how to position a new drug or device to the rest of the world. Still, much of that same planning can be internalized and

Competitive Intelligence Guidelines & Policies Keeping Companies in the Safety Zone

Author:

Competitive Intelligence (CI) groups are instrumental in helping world-class companies to anticipate and respond strategically to external change. Primary and secondary competitive intelligence research helps organizations to improve their chances for success in today’s competitive business environment. While there are

Developing & Maintaining Strategic Professional & Trade Relations Functions

Author:

Professional and trade relations groups are critical for dealing with a company’s critical stakeholder groups, such as professional, payer, and patient organizations. Despite this, these groups still must show value within healthcare organizations, while external trends are constantly shaping the

The First 3 Commandments of Internal Branding

Author:

In the last blog post, I promised to bring greater detail to how pharma companies should brand a product internally before reaching out to the public. The first three “commandments” generally occur during Phase II of a planned drug launch, and provide